1月22日，据美通社消息， 杜邦公司（DuPont de Nemours, Inc.）、科迪华公司（Corteva, Inc.）和科慕公司（The Chemours Company ）宣布，他们已经签署了一份具有约束力的谅解备忘录，其中包含一项解决方案，以解决2015年杜邦公司剥离科慕引发的法律纠纷，并建立一项成本分摊协议和一个托管账户，用于支持和管理2015年7月1日之前产生的潜在PFAS遗留债务。该协议取代了2017年2月的PFOA和解协议以及科慕分离协议的后续修订。此外，杜邦、科迪华和科慕已同意解决俄亥俄州多地区PFOA诉讼中正在进行的问题。

　　DuPont de Nemours, Inc. (NYSE: DD), Corteva, Inc. (NYSE: CTVA) and The Chemours Company (NYSE: CC) today announced they have entered into a binding memorandum of understanding containing a settlement to resolve legal disputes originating from the 2015 spin-off of Chemours from E. I. du Pont de Nemours and Company (EID), and to establish a cost sharing arrangement and an escrow account to be used to support and manage potential future legacy PFAS liabilities arising out of pre-July 1, 2015 conduct. The agreement replaces the February 2017 PFOA Settlement and subsequent amendment to the Chemours Separation Agreement. In addition, DuPont, Corteva and Chemours have agreed to resolve the ongoing matters in the multi-district PFOA litigation in Ohio.
　　根据成本分摊协议的条款，费用将对半分摊，杜邦和科迪华负责一半，科慕公司负责另一半，同意在不超过20年或超过40亿美元的期间内分担某些合理费用。杜邦和科迪华的50%将被限制在20亿美元以内，包括符合条件的支出和代管费用。根据2019年6月1日签订的协议，杜邦和科迪华将分别承担前3亿美元的50%（最高1.5亿美元），剩下的杜邦承担71%，科迪华承担29%。杜邦在潜在的20亿美元中所占的份额约为13.6亿美元，科迪华所占的份额约为6.4亿美元。
　　According to the terms of the cost sharing arrangement, DuPont and Corteva together, on one hand, and Chemours, on the other hand, agree to a 50-50 split of certain qualified expenses incurred over a term not to exceed twenty years or $4 billion of qualified spend and escrow contributions in the aggregate. DuPont and Corteva's 50 percent will be limited to $2 billion including qualified expenses and escrow contributions. Under the existing Letter Agreement from June 1, 2019, DuPont and Corteva will each bear 50 percent of the first $300 million (up to $150 million each) and thereafter, DuPont bears 71 percent and Corteva bears the remaining 29 percent. DuPont's share of the potential $2 billion would be approximately $1.36 billion and Corteva's approximately $640 million.
　　关于上述成本分摊安排，公司还同意设立一个最高10亿美元的托管账户，以应对未来PFAS的潜在负债。根据协议条款，科慕、杜邦和科迪华将在八年内每年向托管机构捐款。在此期间，科慕将向该账户共存入5亿美元，杜邦和科迪华将根据双方协议条款存入另外的5亿美元。如果到2028年12月31日托管账户余额少于7亿美元，托管提供一次性补充机制。
　　In connection with the cost sharing arrangement described above, the companies also agree to establish a $1 billion maximum escrow account to address potential future PFAS liabilities. Subject to the terms of the arrangement, contributions to the escrow will be made by Chemours, on one hand, and DuPont and Corteva, on the other hand, annually over an eight-year period. Over such period, Chemours will deposit a total of $500 million into the account and DuPont and Corteva will deposit an additional $500 million pursuant to the terms of their existing Letter Agreement. The escrow provides for a one-time replenishment mechanism if the escrow account balance has less than $700 million at December 31, 2028.
　　在这项安排期满之后，科慕在《 Chemours分离协议》下的赔偿义务将继续保持不变，但谅解备忘录中规定的某些特定情况除外。
　　After the term of this arrangement, Chemours' indemnification obligations under the Chemours Separation Agreement would continue unchanged, subject to certain exceptions set forth in the memorandum of understanding.
　　此外，杜邦、科迪华和科慕公司已同意以8300万美元解决俄亥俄州多地区PFOA诉讼案。杜邦将出资2700万美元，科迪华将出资2700万美元，科慕公司将出资2900万美元。该协议解决了大约95宗悬而未决的案件。Travis和Julie Abbott诉杜邦一案不包含在和解协议中，目前正在等待上诉。这些数额不受新的费用分摊安排的约束。
　　In addition, DuPont, Corteva and Chemours have agreed to resolve the matters in the Ohio multi-district PFOA litigation for $83 million. DuPont will contribute $27 million, Corteva will contribute $27 million and Chemours will contribute $29 million to the settlement. The agreement resolves approximately 95 pending cases as well as unfiled matters. The case of Travis and Julie Abbott v. E.I. du Pont de Nemours and Company is not included in the settlement and is presently pending appeal. These amounts are not subject to the new cost sharing arrangement.
　　杜邦董事长兼首席执行官埃德·布林（Ed Breen）；科迪华首席执行官吉姆·柯林斯（Jim Collins）和科慕总裁兼首席执行官马克·维格纳诺（Mark Vergnano）对协议发表了评论：
　　“我们很高兴我们的公司就潜在的PFAS遗留债务达成和解协议，并解决俄亥俄州的遗留PFOA MDL案件。该协议将通过透明的程序来处理和解决未来任何潜在的PFAS遗留问题，为每家公司和我们各自的股东提供安全和确定性的措施。”